Herceptin may have greater role in treating HER2-negative breast cancer

[News]

New research from the University of Michigan Comprehensive Cancer Center finds that the protein HER2 plays a role even in breast cancers that would traditionally be categorized as HER2-negative - and that the drug Herceptin, which targets HER2, may have an even greater role for treating breast cancer and preventing its spread.

More... (http://www.news-medical.net/news/20130228/Herceptin-may-have-greater-role-in-treating-HER2-negative-breast-cancer.aspx)